{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T12:08:02Z","timestamp":1749125282058},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T00:00:00Z","timestamp":1642809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T00:00:00Z","timestamp":1642809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Thailand Research Fund (TRF) Senior Research Scholar","award":["RTA6280004"],"award-info":[{"award-number":["RTA6280004"]}]},{"name":"Center of Excellence in Hepatitis and Liver Cancer, Faculty of Medicine, Chulalongkorn University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Individuals with end-stage renal disease have a higher risk of hepatitis C virus (HCV) acquisition during long-term hemodialysis (HD). Our report was designed to investigate HCV prevalence and genotype, in addition to the clinical use of HCV core antigen (HCVcAg), within multiple HD facilities in Thailand.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This cross\u2010sectional report was investigated between January and June 2019. HCV infection was assessed by anti-HCV and confirmed active infection by measuring HCV RNA and HCVcAg. HCV genotype was determined by phylogenetic analysis using nucleotide sequences of NS5B region.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 140 of 3,305 (4.2%) patients in 15 dialysis centers had anti-HCV positive. Among them, HCV RNA was further assessed in 93 patients and was detectable in 59 (63.4%) persons. Considering HCV viremia, HCVcAg measurement exhibited high accuracy (96.8%), sensitivity (94.9%) and specificity (100%) in comparison with HCV RNA testing. Moreover, individuals infected with HCV received a longer duration of dialysis vintage when compared to anti-HCV negative controls. The major sub-genotypes were 1a, 1b, 3a, 3b, 6f and 6n. Regarding phylogenetic analysis, there were 7 clusters of isolates with high sequence homology affecting 17 individuals, indicating possible HCV transmission within the same HD centers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>HCV frequency and common sub-genotypes in HD centers were different from those found in the Thai general population. HCVcAg might be an alternate testing for viremia within resource-limited countries. Enhanced preventive practices, dialyzer reuse policy and better access to antiviral therapy are crucial for HCV micro-elimination within HD facilities.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07074-2","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T18:02:38Z","timestamp":1642874558000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence and genotype distribution of hepatitis C virus within hemodialysis units in Thailand: role of HCV core antigen in the assessment of viremia"],"prefix":"10.1186","volume":"22","author":[{"given":"Natthaya","family":"Chuaypen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apichaya","family":"Khlaiphuengsin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thaninee","family":"Prasoppokakorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paweena","family":"Susantitaphong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wisit","family":"Prasithsirikul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anchalee","family":"Avihingsanon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pisit","family":"Tangkijvanich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kearkiat","family":"Praditpornsilpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,22]]},"reference":[{"issue":"10207","key":"7074_CR1","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","volume":"394","author":"CW Spearman","year":"2019","unstructured":"Spearman CW, Dusheiko GM, Hellard M, Sonderup M. Hepatitis C. Lancet. 2019;394(10207):1451\u201366. https:\/\/doi.org\/10.1016\/S0140-6736(19)32320-7.","journal-title":"Lancet"},{"issue":"1","key":"7074_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/hep.26744","volume":"59","author":"DB Smith","year":"2014","unstructured":"Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology. 2014;59(1):318\u201327. https:\/\/doi.org\/10.1002\/hep.26744.","journal-title":"Hepatology"},{"issue":"2","key":"7074_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149362","volume":"11","author":"R Wasitthankasem","year":"2016","unstructured":"Wasitthankasem R, Posuwan N, Vichaiwattana P, Theamboonlers A, Klinfueng S, Vuthitanachot V, et al. Decreasing hepatitis C virus infection in Thailand in the past decade: evidence from the 2014 national survey. PLoS ONE. 2016;11(2): e0149362. https:\/\/doi.org\/10.1371\/journal.pone.0149362.","journal-title":"PLoS ONE"},{"issue":"9","key":"7074_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","volume":"10","author":"B Hajarizadeh","year":"2013","unstructured":"Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol. 2013;10(9):553\u201362.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"7074_CR5","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1007\/s10620-015-3801-y","volume":"60","author":"F Fabrizi","year":"2015","unstructured":"Fabrizi F, Verdesca S, Messa P, Martin P. Hepatitis C virus infection increases the risk of developing chronic kidney disease: a systematic review and meta-analysis. Dig Dis Sci. 2015;60(12):3801\u201313. https:\/\/doi.org\/10.1007\/s10620-015-3801-y.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"7074_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41581-018-0081-8","volume":"15","author":"S Pol","year":"2019","unstructured":"Pol S, Parlati L, Jadoul M. Hepatitis C virus and the kidney. Nat Rev Nephrol. 2019;15(2):73\u201386. https:\/\/doi.org\/10.1038\/s41581-018-0081-8.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"7074_CR7","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1053\/j.gastro.2018.10.033","volume":"156","author":"GN Ioannou","year":"2019","unstructured":"Ioannou GN, Feld JJ. What are the benefits of a sustained virologic response to direct-acting antiviral therapy for hepatitis C virus infection? Gastroenterology. 2019;156(2):446-60.e2. https:\/\/doi.org\/10.1053\/j.gastro.2018.10.033.","journal-title":"Gastroenterology"},{"issue":"2","key":"7074_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/sdi.12761","volume":"32","author":"DB Nguyen","year":"2019","unstructured":"Nguyen DB, Bixler D, Patel PR. Transmission of hepatitis C virus in the dialysis setting and strategies for its prevention. Semin Dial. 2019;32(2):127\u201334. https:\/\/doi.org\/10.1111\/sdi.12761.","journal-title":"Semin Dial"},{"issue":"2","key":"7074_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/sdi.12757","volume":"32","author":"F Fabrizi","year":"2019","unstructured":"Fabrizi F, Messa P. The epidemiology of HCV infection in patients with advanced CKD\/ESRD: a global perspective. Semin Dial. 2019;32(2):93\u20138. https:\/\/doi.org\/10.1111\/sdi.12757.","journal-title":"Semin Dial"},{"issue":"3","key":"7074_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.kisu.2018.06.001","volume":"8","author":"Kidney Disease: Improving Global Outcomes Hepatitis CWG","year":"2018","unstructured":"Kidney Disease: Improving Global Outcomes Hepatitis CWG. KDIGO 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis c in chronic kidney disease. Kidney Int Suppl. 2018;8(3):91\u2013165. https:\/\/doi.org\/10.1016\/j.kisu.2018.06.001.","journal-title":"Kidney Int Suppl"},{"issue":"5","key":"7074_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.7326\/M16-0065","volume":"165","author":"JM Freiman","year":"2016","unstructured":"Freiman JM, Tran TM, Schumacher SG, White LF, Ongarello S, Cohn J, et al. Hepatitis C core antigen testing for diagnosis of hepatitis C virus infection: a systematic review and meta-analysis. Ann Intern Med. 2016;165(5):345\u201355. https:\/\/doi.org\/10.7326\/M16-0065.","journal-title":"Ann Intern Med"},{"issue":"12","key":"7074_CR12","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/S2468-1253(18)30271-1","volume":"3","author":"M van Tilborg","year":"2018","unstructured":"van Tilborg M, Al Marzooqi SH, Wong WWL, Maan R, Vermehren J, Maasoumy B, et al. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies. Lancet Gastroenterol Hepatol. 2018;3(12):856\u201364. https:\/\/doi.org\/10.1016\/S2468-1253(18)30271-1.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"7074_CR13","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/hep.24105","volume":"53","author":"ZH Lin","year":"2011","unstructured":"Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011;53(3):726\u201336. https:\/\/doi.org\/10.1002\/hep.24105.","journal-title":"Hepatology"},{"issue":"6","key":"7074_CR14","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1128\/JCM.00487-12","volume":"50","author":"A Murayama","year":"2012","unstructured":"Murayama A, Sugiyama N, Watashi K, Masaki T, Suzuki R, Aizaki H, et al. Japanese reference panel of blood specimens for evaluation of hepatitis C virus RNA and core antigen quantitative assays. J Clin Microbiol. 2012;50(6):1943\u20139. https:\/\/doi.org\/10.1128\/JCM.00487-12.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"7074_CR15","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3892\/ijmm.2015.2321","volume":"36","author":"B Nie","year":"2015","unstructured":"Nie B, Zhang G, Guo Y, Li Q, Liu J, Tu Z. Phylogenetic analysis of HCV subgenotypes in patients from Sichuan province in China based on the NS5B region. Int J Mol Med. 2015;36(4):1028\u201334. https:\/\/doi.org\/10.3892\/ijmm.2015.2321.","journal-title":"Int J Mol Med"},{"issue":"5","key":"7074_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178225","volume":"12","author":"S El Hadad","year":"2017","unstructured":"El Hadad S, Al-Hamdan H, Linjawi S. Partial sequencing analysis of the NS5B region confirmed the predominance of hepatitis C virus genotype 1 infection in Jeddah, Saudi Arabia. PLoS ONE. 2017;12(5): e0178225. https:\/\/doi.org\/10.1371\/journal.pone.0178225.","journal-title":"PLoS ONE"},{"issue":"2","key":"7074_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/BF01731581","volume":"16","author":"M Kimura","year":"1980","unstructured":"Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 1980;16(2):111\u201320. https:\/\/doi.org\/10.1007\/BF01731581.","journal-title":"J Mol Evol"},{"issue":"12","key":"7074_CR18","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1093\/cid\/ciz160","volume":"69","author":"C Rami\u00e8re","year":"2019","unstructured":"Rami\u00e8re C, Charre C, Miailhes P, Bailly F, Radenne S, Uhres AC, Brochier C, Godinot M, Chiarello P, Pradat P, Cotte L, Lyon Acute Hepatitis Study Group. Patterns of Hepatitis C Virus Transmission in Human Immunodeficiency Virus (HIV)-infected and HIV-negative Men Who Have Sex With Men. Clin Infect Dis. 2019;69(12):2127\u201335. https:\/\/doi.org\/10.1093\/cid\/ciz160.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"7074_CR19","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.ekir.2020.05.001","volume":"5","author":"PK Li","year":"2020","unstructured":"Li PK, Bavanandan S, Mohamed R, Szeto CC, Wong VW, Chow KM, et al. 2018 kidney disease: improving global outcomes (KDIGO) Hepatitis C in chronic kidney disease guideline implementation: Asia Summit Conference Report. Kidney Int Rep. 2020;5(8):1129\u201338. https:\/\/doi.org\/10.1016\/j.ekir.2020.05.001.","journal-title":"Kidney Int Rep"},{"issue":"5","key":"7074_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1159\/000351621","volume":"56","author":"S Akkarathamrongsin","year":"2013","unstructured":"Akkarathamrongsin S, Hacharoen P, Tangkijvanich P, Theamboonlers A, Tanaka Y, Mizokami M, et al. Molecular epidemiology and genetic history of hepatitis C virus subtype 3a infection in Thailand. Intervirology. 2013;56(5):284\u201394. https:\/\/doi.org\/10.1159\/000351621.","journal-title":"Intervirology"},{"issue":"11\u201312","key":"7074_CR21","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1046\/j.1365-2036.2003.01780.x","volume":"18","author":"F Fabrizi","year":"2003","unstructured":"Fabrizi F, Dulai G, Dixit V, Bunnapradist S, Martin P. Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther. 2003;18(11\u201312):1071\u201381. https:\/\/doi.org\/10.1046\/j.1365-2036.2003.01780.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"7074_CR22","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.ajic.2016.01.014","volume":"44","author":"CM Duong","year":"2016","unstructured":"Duong CM, McLaws ML. An investigation of an outbreak of hepatitis C virus infections in a low-resourced hemodialysis unit in Vietnam. Am J Infect Control. 2016;44(5):560\u20136. https:\/\/doi.org\/10.1016\/j.ajic.2016.01.014.","journal-title":"Am J Infect Control"},{"issue":"8","key":"7074_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041266","volume":"7","author":"L Dunford","year":"2012","unstructured":"Dunford L, Carr MJ, Dean J, Waters A, Nguyen LT, Ta Thi TH, et al. Hepatitis C virus in Vietnam: high prevalence of infection in dialysis and multi-transfused patients involving diverse and novel virus variants. PLoS ONE. 2012;7(8): e41266. https:\/\/doi.org\/10.1371\/journal.pone.0041266.","journal-title":"PLoS ONE"},{"issue":"10","key":"7074_CR24","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.cmi.2016.07.035","volume":"22","author":"S Lanini","year":"2016","unstructured":"Lanini S, Easterbrook PJ, Zumla A, Ippolito G. Hepatitis C: global epidemiology and strategies for control. Clin Microbiol Infect. 2016;22(10):833\u20138. https:\/\/doi.org\/10.1016\/j.cmi.2016.07.035.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"7074_CR25","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1111\/jgh.12613","volume":"29","author":"A Avihingsanon","year":"2014","unstructured":"Avihingsanon A, Jitmitraparp S, Tangkijvanich P, Ramautarsing RA, Apornpong T, Jirajariyavej S, et al. Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase\/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels. J Gastroenterol Hepatol. 2014;29(9):1706\u201314. https:\/\/doi.org\/10.1111\/jgh.12613.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"7074_CR26","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1093\/ndt\/gfn684","volume":"24","author":"DW Johnson","year":"2009","unstructured":"Johnson DW, Dent H, Yao Q, Tranaeus A, Huang CC, Han DS, et al. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Nephrol Dial Transplant. 2009;24(5):1598\u2013603. https:\/\/doi.org\/10.1093\/ndt\/gfn684.","journal-title":"Nephrol Dial Transplant"},{"key":"7074_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16081453","author":"G Cai","year":"2019","unstructured":"Cai G, Zheng H, Luo L, Wang Z, Jiang Z, Xu S, et al. Factors correlating to the development of hepatitis C virus infection in hemodialysis patients-findings mainly from asiatic populations: a systematic review and meta-analysis. Int J Environ Res Public Health. 2019. https:\/\/doi.org\/10.3390\/ijerph16081453.","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"7074_CR28","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1046\/j.1365-2893.2002.00374.x","volume":"9","author":"S Kokubo","year":"2002","unstructured":"Kokubo S, Horii T, Yonekawa O, Ozawa N, Mukaide M. A phylogenetic-tree analysis elucidating nosocomial transmission of hepatitis C virus in a haemodialysis unit. J Viral Hepatitis. 2002;9(6):450\u20134. https:\/\/doi.org\/10.1046\/j.1365-2893.2002.00374.x.","journal-title":"J Viral Hepatitis"},{"issue":"3","key":"7074_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s100960050456","volume":"19","author":"YH Abacioglu","year":"2000","unstructured":"Abacioglu YH, Bacaksiz F, Bahar IH, Simmonds P. Molecular evidence of nosocomial transmission of hepatitis C virus in a haemodialysis unit. Eur J Clin Microbiol Infect Dis. 2000;19(3):182\u20136. https:\/\/doi.org\/10.1007\/s100960050456.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"7074_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jhin.2017.01.002","volume":"96","author":"MI Garvey","year":"2017","unstructured":"Garvey MI, Bradley CW, Holden KL, Hewins P, Ngui SL, Tedder R, et al. Use of genome sequencing to identify hepatitis C virus transmission in a renal healthcare setting. J Hosp Infect. 2017;96(2):157\u201362. https:\/\/doi.org\/10.1016\/j.jhin.2017.01.002.","journal-title":"J Hosp Infect"},{"issue":"4","key":"7074_CR31","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.kint.2018.06.011","volume":"94","author":"M Jadoul","year":"2018","unstructured":"Jadoul M, Berenguer MC, Doss W, Fabrizi F, Izopet J, Jha V, et al. Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management. Kidney Int. 2018;94(4):663\u201373. https:\/\/doi.org\/10.1016\/j.kint.2018.06.011.","journal-title":"Kidney Int"},{"key":"7074_CR32","doi-asserted-by":"publisher","DOI":"10.7326\/M19-1539","author":"CE Gordon","year":"2019","unstructured":"Gordon CE, Berenguer MC, Doss W, Fabrizi F, Izopet J, Jha V, et al. Prevention, diagnosis, evaluation, and treatment of hepatitis C virus infection in chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2018 clinical practice guideline. Ann Intern Med. 2019. https:\/\/doi.org\/10.7326\/M19-1539.","journal-title":"Ann Intern Med"},{"issue":"1 Suppl","key":"7074_CR33","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1016\/j.jhep.2016.08.002","volume":"65","author":"PJ Easterbrook","year":"2016","unstructured":"Easterbrook PJ, Group WHOGD. Who to test and how to test for chronic hepatitis C infection\u20142016 WHO testing guidance for low- and middle-income countries. J Hepatol. 2016;65(1 Suppl):S46\u201366. https:\/\/doi.org\/10.1016\/j.jhep.2016.08.002.","journal-title":"J Hepatol"},{"issue":"2","key":"7074_CR34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jcv.2011.11.009","volume":"53","author":"I Mederacke","year":"2012","unstructured":"Mederacke I, Potthoff A, Meyer-Olson D, Meier M, Raupach R, Manns MP, et al. HCV core antigen testing in HIV- and HBV-coinfected patients, and in HCV-infected patients on hemodialysis. J Clin Virol. 2012;53(2):110\u20135. https:\/\/doi.org\/10.1016\/j.jcv.2011.11.009.","journal-title":"J Clin Virol"},{"issue":"1","key":"7074_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jcv.2010.02.012","volume":"48","author":"M Miedouge","year":"2010","unstructured":"Miedouge M, Saune K, Kamar N, Rieu M, Rostaing L, Izopet J. Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients. J Clin Virol. 2010;48(1):18\u201321. https:\/\/doi.org\/10.1016\/j.jcv.2010.02.012.","journal-title":"J Clin Virol"},{"key":"7074_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12204","author":"B Heidrich","year":"2013","unstructured":"Heidrich B, Pischke S, Helfritz FA, Mederacke I, Kirschner J, Schneider J, et al. Hepatitis C virus core antigen testing in liver and kidney transplant recipients. J Viral Hepat. 2013. https:\/\/doi.org\/10.1111\/jvh.12204.","journal-title":"J Viral Hepat"},{"issue":"2","key":"7074_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000370070","volume":"58","author":"VD Thong","year":"2015","unstructured":"Thong VD, Akkarathamrongsin S, Avihingsanon A, Theamboonlers A, Poovorawan Y, Tangkijvanich P. The correlation between hepatitis C core antigen and hepatitis C virus RNA levels with respect to human immunodeficiency virus status, hepatitis C virus genotype and interferon-lambda-4 polymorphism. Intervirology. 2015;58(2):73\u20139. https:\/\/doi.org\/10.1159\/000370070.","journal-title":"Intervirology"},{"issue":"15","key":"7074_CR38","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1056\/NEJMoa1704053","volume":"377","author":"E Gane","year":"2017","unstructured":"Gane E, Lawitz E, Pugatch D, Papatheodoridis G, Brau N, Brown A, et al. Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment. N Engl J Med. 2017;377(15):1448\u201355. https:\/\/doi.org\/10.1056\/NEJMoa1704053.","journal-title":"N Engl J Med"},{"issue":"10003","key":"7074_CR39","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/S0140-6736(15)00349-9","volume":"386","author":"D Roth","year":"2015","unstructured":"Roth D, Nelson DR, Bruchfeld A, Liapakis A, Silva M, Monsour H Jr, et al. Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4\u20135 chronic kidney disease (the C-SURFER study): a combination phase 3 study. Lancet. 2015;386(10003):1537\u201345. https:\/\/doi.org\/10.1016\/S0140-6736(15)00349-9.","journal-title":"Lancet"},{"issue":"6","key":"7074_CR40","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/liv.13102","volume":"36","author":"V Saxena","year":"2016","unstructured":"Saxena V, Koraishy FM, Sise ME, Lim JK, Schmidt M, Chung RT, et al. Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function. Liver Int. 2016;36(6):807\u201316. https:\/\/doi.org\/10.1111\/liv.13102.","journal-title":"Liver Int"},{"issue":"10003","key":"7074_CR41","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/S0140-6736(15)00381-5","volume":"386","author":"M Jadoul","year":"2015","unstructured":"Jadoul M, Horsmans Y. Towards eradication of hepatitis C virus from dialysis units. Lancet. 2015;386(10003):1514\u20135. https:\/\/doi.org\/10.1016\/S0140-6736(15)00381-5.","journal-title":"Lancet"},{"issue":"6","key":"7074_CR42","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1053\/j.gastro.2012.02.017","volume":"142","author":"L Castera","year":"2012","unstructured":"Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology. 2012;142(6):1293-302.e4. https:\/\/doi.org\/10.1053\/j.gastro.2012.02.017.","journal-title":"Gastroenterology"},{"issue":"10","key":"7074_CR43","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/cid\/ciy585","volume":"67","author":"Panel A-IHG","year":"2018","unstructured":"Panel A-IHG. Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection. Clin Infect Dis. 2018;67(10):1477\u201392. https:\/\/doi.org\/10.1093\/cid\/ciy585.","journal-title":"Clin Infect Dis"},{"key":"7074_CR44","unstructured":"Clinical Practice Guidelines and Clinical Practice Recommendations 2006 Updates. http:\/\/kidneyfoundation.cachefly.net\/professionals\/KDOQI\/guideline_upHD_PD_VA\/index.htm. Accessed 26 Nov 2021."},{"issue":"3","key":"7074_CR45","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000336532","volume":"35","author":"TF Galvao","year":"2012","unstructured":"Galvao TF, Silva MT, Araujo ME, Bulbol WS, Cardoso AL. Dialyzer reuse and mortality risk in patients with end-stage renal disease: a systematic review. Am J Nephrol. 2012;35(3):249\u201358. https:\/\/doi.org\/10.1159\/000336532.","journal-title":"Am J Nephrol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07074-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07074-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07074-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T18:02:46Z","timestamp":1642874566000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07074-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,22]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7074"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07074-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,22]]},"assertion":[{"value":"13 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients gave their informed written consent. The study was reviewed and approved by the Institutional Review Board, Faculty of Medicine, Chulalongkorn University. The study was performed in accordance with Declaration of Helsinki for the participation of human individuals. Information regarding demographic data were collected using a standardized questionnaire.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}